Archives of Endocrinology Metabolism最新文献

筛选
英文 中文
Leptin 30 years - A chat with Jeffrey M. Friedman. 瘦素30年——与杰弗里·弗里德曼的谈话。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-11 DOI: 10.20945/2359-4292-2024-0413
Alexandre Moura-Assis, Licio A Velloso
{"title":"Leptin 30 years - A chat with Jeffrey M. Friedman.","authors":"Alexandre Moura-Assis, Licio A Velloso","doi":"10.20945/2359-4292-2024-0413","DOIUrl":"https://doi.org/10.20945/2359-4292-2024-0413","url":null,"abstract":"","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"68 ","pages":"e240413"},"PeriodicalIF":1.6,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive factors for permanent hypoparathyroidism following total thyroidectomy: A retrospective cohort study of 5,671 cases. 全甲状腺切除术后永久性甲状旁腺功能减退的预测因素:5671例回顾性队列研究。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-11 DOI: 10.20945/2359-4292-2024-0379
Daniela Tamega Joaquim, Hugo Fontan Kohler, José Guilherme Vartanian, Luiz Paulo Kowalski, Genival Barbosa de Carvalho
{"title":"Predictive factors for permanent hypoparathyroidism following total thyroidectomy: A retrospective cohort study of 5,671 cases.","authors":"Daniela Tamega Joaquim, Hugo Fontan Kohler, José Guilherme Vartanian, Luiz Paulo Kowalski, Genival Barbosa de Carvalho","doi":"10.20945/2359-4292-2024-0379","DOIUrl":"https://doi.org/10.20945/2359-4292-2024-0379","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the rates of permanent hypoparathyroidism based on demographic variables, patient comorbidities, clinical staging of the disease, surgery performed, and severity of transient hypoparathyroidism.</p><p><strong>Subjects and methods: </strong>This is a retrospective cohort study with patients who underwent total thyroidectomy with or without neck dissection between January 2014 and December 2021.</p><p><strong>Results: </strong>5,671 patients were analyzed, 966 (17)%) presented transient hypoparathyroidism and 106 (1.8%) developed permanent hypoparathyroidism. The logistic regression model analyzing the cohort of patients with transient hypoparathyroidism demonstrates that the number of dissected lymph nodes from the central compartment, immediate postoperative PTH levels, the necessity of postoperative intravenous (IV) calcium supplementation and the duration of IV calcium supplementation are significant predictors. When applied to the original dataset, this model presents a NPV of 1.0000 and a PPV of 0.9594 with an overall accuracy of 0.9624.</p><p><strong>Conclusion: </strong>The incidence of permanent hypoparathyroidism was closely associated with the extent of level VI dissection, particularly regarding the number of lymph nodes removed and whether the dissection was bilateral. Furthermore, the severity of post-operative hypocalcemia was demonstrated by the decrease in PTH levels, as well as the need for and duration of intravenous calcium supplementation.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"68 ","pages":"e240379"},"PeriodicalIF":1.6,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144057804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic significance of the pan-immune-inflammation value (PIV) in patients with differentiated thyroid carcinoma. 泛免疫炎症值(PIV)在分化型甲状腺癌患者中的预后意义。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-11 DOI: 10.20945/2359-4292-2024-0217
Yusuf Öztürk, Muhammet Kocabaş, Melia Karaköse, Mustafa Kulaksizoğlu, Feridun Karakurt
{"title":"Prognostic significance of the pan-immune-inflammation value (PIV) in patients with differentiated thyroid carcinoma.","authors":"Yusuf Öztürk, Muhammet Kocabaş, Melia Karaköse, Mustafa Kulaksizoğlu, Feridun Karakurt","doi":"10.20945/2359-4292-2024-0217","DOIUrl":"https://doi.org/10.20945/2359-4292-2024-0217","url":null,"abstract":"<p><strong>Objective: </strong>The pan-immune-inflammation value (PIV) is a novel inflammatory biomarker for evaluating inflammatory status in patients with cancer. The aim of this study was to evaluate the prognostic value of PIV in patients with differentiated thyroid cancers (DTCs).</p><p><strong>Subjects and methods: </strong>The study included 376 patients with DTC who underwent curative resection. The PIV was calculated using the formula (neutrophils × monocytes × platelets)/lymphocytes. The TNM stages 3-4 were considered advanced. Patients were also categorized into low-, intermediate-, and high-risk groups according to the AmericanThyroid Association (ATA) risk classification system. Demographic, laboratory, and clinicopathological data were obtained from the patients' files. The predictive value of PIV on TNM advanced stage, ATA high-risk category, and distant metastases was evaluated using receiver operating characteristic (ROC) curve analysis.</p><p><strong>Results: </strong>The optimal PIV values for predicting TNM advanced stage, ATA high-risk category, and distant metastases were, respectively, 331.62 (area under the curve [AUC] 0.730, sensitivity 66.7%, specificity 64.8%), 365.52 (AUC 0.822, sensitivity 79.5%, specificity 76.9%), and 357.65 (AUC 0.774, sensitivity 75.2%, specificity 72%). On regression analysis, PIV ≥ 365.52 (odds ratio [OR] 29.150, 95% confidence interval [CI] 8.148-104.290, p < 0.001) and PIV ≥ 357.65 (OR 7.224, 95% CI 1.700-30.693, p = 0.007) emerged as independent risk factors for ATA high-risk category and distant metastases, respectively.</p><p><strong>Conclusion: </strong>Among patients with DTC, PIV is an independent risk factor for distant metastases and ATA high-risk category. While this finding must be supported by more comprehensive studies, PIV has the potential to be used as a prognostic biomarker in these patients.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"68 ","pages":"e240217"},"PeriodicalIF":1.6,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between type 2 diabetes and dietary antioxidant index: a cross-sectional study in the Iranian population. 2型糖尿病与饮食抗氧化指数之间的关系:伊朗人群的横断面研究
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-11 DOI: 10.20945/2359-4292-2024-0170
Zahra Roumi, Majid Kamali, Masoomeh Alsadat Mirshafaei, Saheb Abbas Torki, Bahareh Aminnezhad, Zahra Mahmoudi, Soheila Shekari, Ali Shamsi-Goushki, Kadijeh Abbasi Mobarakeh, Masoomeh Ataei Kachooei, Maryam Gholamalizadeh, Saeed Omidi, Parsa Bahmani, Saeid Doaei, Hamideh YazdiMoghaddam
{"title":"The association between type 2 diabetes and dietary antioxidant index: a cross-sectional study in the Iranian population.","authors":"Zahra Roumi, Majid Kamali, Masoomeh Alsadat Mirshafaei, Saheb Abbas Torki, Bahareh Aminnezhad, Zahra Mahmoudi, Soheila Shekari, Ali Shamsi-Goushki, Kadijeh Abbasi Mobarakeh, Masoomeh Ataei Kachooei, Maryam Gholamalizadeh, Saeed Omidi, Parsa Bahmani, Saeid Doaei, Hamideh YazdiMoghaddam","doi":"10.20945/2359-4292-2024-0170","DOIUrl":"https://doi.org/10.20945/2359-4292-2024-0170","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to explore the association between dietary antioxidant index (DAI) and type 2 diabetes (T2D) in the Iranian population.</p><p><strong>Subjects and methods: </strong>The present cross- sectional study comprised 4,241 participants aged from 35 to 70. A food frequency questionnaire (FFQ) was used to assess dietary intake. The DAI score was determined using Wright's method, which quantifies the antioxidant content of the diet. Logistic and linear regression analyses were used to determine the link between DAI and T2D after adjusting for confounding variables.</p><p><strong>Results: </strong>Negative associations were found between T2D with total score of DAI (OR = 0.67, CI95%: 0.55-0.81, P = 0.001) and DAI score of zinc (OR = 0.53, CI95%: 0.40-0.72, P = 0.001), manganese (OR = 0.77, CI95%: 0.68-0.88, P = 0.001), and selenium (OR = 0.88, CI95%: 0.78-0.98, P = 0.010) after adjustments for age, sex, BMI, education level, marital status, occupation, physical activity, and calorie intake.</p><p><strong>Conclusion: </strong>These results indicate the significance of an antioxidant-rich diet in preventing T2D and its complications. Nevertheless, additional investigation is required to validate these findings and explore the fundamental mechanisms of the association of T2D and dietary antioxidants.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"68 ","pages":"e240170"},"PeriodicalIF":1.6,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low testosterone is associated with steatosis in the male population with spinal cord injury. 在脊髓损伤的男性人群中,低睾酮与脂肪变性有关。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-11 DOI: 10.20945/2359-4292-2024-0047
Fernanda Barros Viana Coelho, José Tadeu Stefano, Claudia Pinto Marques Souza de Oliveira
{"title":"Low testosterone is associated with steatosis in the male population with spinal cord injury.","authors":"Fernanda Barros Viana Coelho, José Tadeu Stefano, Claudia Pinto Marques Souza de Oliveira","doi":"10.20945/2359-4292-2024-0047","DOIUrl":"https://doi.org/10.20945/2359-4292-2024-0047","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in men with spinal cord injury (SCI) and to identify the independent factors associated with steatosis.</p><p><strong>Subjects and methods: </strong>This is a cross-sectional study. Inclusion criteria were males over 18 years of age with chronic traumatic SCI enrolled in a rehabilitation programme. A multivariable logistic regression model was constructed using a stepwise variable selection procedure.</p><p><strong>Results: </strong>After exclusion criteria, 160 participants were included. The prevalence of MASLD was 19%. Men with hepatic steatosis were older, had a higher prevalence of hypogonadism, obesity and diabetes mellitus. Additionally, they exhibited significantly higher levels of ALT, AST and GGT. The mean time since the SCI was 7.8 years in those with steatosis and 4.3 years in those without. Multiple logistic regression analysis revealed age (p < 0.001 OR: 1.07), time since SCI (p = 0.025, OR: 1.11) and total testosterone ≤ 300 ng/dL (p = 0.036, OR: 3.35) as significant independent variables associated with steatosis.</p><p><strong>Conclusion: </strong>Our findings suggest a prevalence of MASLD in men with SCI similar to that of the general population. Independent factors associated with steatosis were age, time since injury and total testosterone. Notably, individuals with testosterone levels ≤ 300 ng/dL were 3.35 times more likely to have steatosis compared to those with higher testosterone levels.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"68 ","pages":"e240047"},"PeriodicalIF":1.6,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967168/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144009730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunomodulatory agents and cell therapy for patients with type 1 diabetes. 1型糖尿病患者的免疫调节剂和细胞治疗。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-11 DOI: 10.20945/2359-4292-2024-0233
Melanie Rodacki, Karina Ribeiro Silva, Debora Batista Araujo, Joana R Dantas, Maria Eduarda Nascimento Ramos, Lenita Zajdenverg, Leandra Santos Baptista
{"title":"Immunomodulatory agents and cell therapy for patients with type 1 diabetes.","authors":"Melanie Rodacki, Karina Ribeiro Silva, Debora Batista Araujo, Joana R Dantas, Maria Eduarda Nascimento Ramos, Lenita Zajdenverg, Leandra Santos Baptista","doi":"10.20945/2359-4292-2024-0233","DOIUrl":"https://doi.org/10.20945/2359-4292-2024-0233","url":null,"abstract":"<p><p>Type 1 diabetes (TID) is a chronic disease caused by autoimmune destruction of pancreatic β-cells, that progresses in three stages: 1) stage 1: β-cell autoimmunity + normoglycemia; 2) stage 2: β-cell autoimmunity + mild dysglycemia; 3) stage 3: symptomatic disease + hyperglycemia. Interventions to prevent or cure T1D in the various stages of the disease have been pursued and may target the prevention of the destruction of β cells, regression of insulitis, preservation or recovery of β cells residual mass. Some therapies show promising results that might change the natural history and the approach to patients with T1D in the next few years. Teplizumab, a humanized monoclonal antibody that binds to CD3, was recently approved in the USA to delay Stage 3 T1D in individuals ≥ 8 years of age. Other non-cellular immunomodulatory therapies, both antigen-specific and non-specific, have shown interesting results either in patients with stage 2 or recent onset stage 3 T1D. Cell therapies such as non-myeloablative transplantation of autologous hematopoietic stem cells, mesenchymal stem cells, and tolerogenic dendritic cells have been also studied in these individuals, aiming immunomodulation. Stem cell-derived islet replacement therapy is promising for patients with long- standing T1D, especially with asymptomatic hypoglycemia not resolved by technology. This review aimed to provide updated information on the main immunomodulatory agents and cell therapy options for type 1 diabetes.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"68 ","pages":"e240233"},"PeriodicalIF":1.6,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New onset diabetes manifesting as diabetic ketoacidosis in a patient with chronic myelogenous leukemia treated with imatinib. 新发糖尿病表现为糖尿病酮症酸中毒的慢性骨髓性白血病患者伊马替尼治疗。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-08 DOI: 10.20945/2359-4292-2024-0432
Dinara Salimova, Tatevik Aloyan, Ursula Qureshi, Faisal Qureshi, Hina Wazir
{"title":"New onset diabetes manifesting as diabetic ketoacidosis in a patient with chronic myelogenous leukemia treated with imatinib.","authors":"Dinara Salimova, Tatevik Aloyan, Ursula Qureshi, Faisal Qureshi, Hina Wazir","doi":"10.20945/2359-4292-2024-0432","DOIUrl":"10.20945/2359-4292-2024-0432","url":null,"abstract":"<p><p>Imatinibis a commonly used antiproliferative agent for treating chronic myelogenous leukemia and gastrointestinal stromal tumors, and it is also thought to be effective in other areas, such as rheumatologic diseases. It has been shown to improve glucose control in diabetic patients by lowering blood sugar, reducing HbA1c levels, and decreasing the need for diabetes medications. However, we present a rare occurrence of severe hyperglycemia and newly elevated HbA1c in a patient on imatinib with no prior history of diabetes. It underscores the need for further research to assess the safety and impact of imatinib on glucose metabolism.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"69 2","pages":"e240432"},"PeriodicalIF":1.6,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11977861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-related characteristics in differentiated thyroid cancer: a 20-year single-center retrospective analysis in pediatric and adolescent patients. 分化型甲状腺癌的年龄相关特征:一项针对儿童和青少年患者的20年单中心回顾性分析
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-08 DOI: 10.20945/2359-4292-2024-0333
Laura Leite-Almeida, Rita Santos Silva, Margarida Vicente-Ferreira, Carla Costa, Norberto Estevinho, Cíntia Castro-Correia, Sofia Ferreira, Maria Bom-Sucesso
{"title":"Age-related characteristics in differentiated thyroid cancer: a 20-year single-center retrospective analysis in pediatric and adolescent patients.","authors":"Laura Leite-Almeida, Rita Santos Silva, Margarida Vicente-Ferreira, Carla Costa, Norberto Estevinho, Cíntia Castro-Correia, Sofia Ferreira, Maria Bom-Sucesso","doi":"10.20945/2359-4292-2024-0333","DOIUrl":"10.20945/2359-4292-2024-0333","url":null,"abstract":"<p><strong>Objective: </strong>To characterize a cohort of pediatric thyroid cancer patients, focusing on clinical features and outcomes stratified by age. Subjects and.</p><p><strong>Methods: </strong>This retrospective analysis included 63 pediatric differentiated thyroid cancer patients treated at a Portuguese pediatric reference hospital over a period of 20 years. Data extracted from clinical records covered demographics, clinical presentation, family history, tumor characteristics, treatment modalities, complications, disease status, and survival outcomes. Patients younger than 12 years were compared to those aged 12 and older.</p><p><strong>Results: </strong>The mean age at diagnosis of the sample was 14.5 years, with a preponderance of female patients. Clinical presentation varied significantly between age groups; younger patients were more likely to present palpable cervical lymph nodes, while older patients frequently had solitary thyroid nodules. Family history and identifiable risk factors were similar across groups. However, older patients had higher rates of prior neoplasia and radiation exposure. Age also influenced surgical treatment and outcomes, including complications and recurrence rates.</p><p><strong>Conclusion: </strong>Our findings corroborate previous evidence on the predominance of papillary carcinoma and the association between radiation exposure and thyroid cancer. Younger patients demonstrated more aggressive tumor characteristics and higher recurrence rates, underscoring the need for age-specific management strategies. Early detection, comprehensive surgical intervention, and multidisciplinary follow-up are essential for achieving optimal outcomes.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"69 2","pages":"e240333"},"PeriodicalIF":1.6,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11987499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143813107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double pituitary adenoma associated with acromegaly and hyperprolactinemia: a case report. 双垂体腺瘤合并肢端肥大症和高泌乳素血症1例。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-08 DOI: 10.20945/2359-4292-2024-0065
María Gabriela García Falcone, Santiago Gonzalez Abbati, Soledad Sosa, Andrea Paes de Lima, Florencia Peralta, Karina Danilowicz
{"title":"Double pituitary adenoma associated with acromegaly and hyperprolactinemia: a case report.","authors":"María Gabriela García Falcone, Santiago Gonzalez Abbati, Soledad Sosa, Andrea Paes de Lima, Florencia Peralta, Karina Danilowicz","doi":"10.20945/2359-4292-2024-0065","DOIUrl":"10.20945/2359-4292-2024-0065","url":null,"abstract":"<p><p>Doubleor multiple adenomas are rare, and synchronous secretory pituitary adenomas are rarer still. We report a case of a 30-year-old woman with a 6-year history of amenorrhea and occasional galactorrhoea. She presented with headaches, weight gain, subtle acromegalic features, new-onset hypertension and diabetes. Workup confirmed acromegaly and hyperprolactinemia. Preoperative magnetic resonance imaging of the pituitary demonstrated two noncontiguous microadenomas. Two distinct tumors were resected through a transsphenoidal approach. Immunohistochemical analysis of each separated adenoma confirmed the diagnosis of acromegaly and prolactinoma. Postoperatively, she was cured of acromegaly, and her amenorrhea/galactorrhea syndrome resolved. Her growth hormone and insulin-like growth factor-I levels normalized, whereas her prolactin level remained slightly above normal. Therefore, it is critical to consider double or multiple adenomas preoperatively through careful endocrine assessment and review of magnetic resonance imaging. As shown in our case, careful evaluation led to a better surgical outcome.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"69 2","pages":"e240065"},"PeriodicalIF":1.6,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11977611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors associated with gestational transient thyrotoxicosis and their effects on the pregnancy course. 妊娠期短暂性甲状腺毒症的相关危险因素及其对妊娠过程的影响。
IF 1.6 4区 医学
Archives of Endocrinology Metabolism Pub Date : 2025-04-08 DOI: 10.20945/2359-4292-2024-0129
Bagdagul Yuksel Guler, Ibrahim Demirci, Cem Haymana, Alper Sonmez, Ahmet Faruk Yagci
{"title":"Risk factors associated with gestational transient thyrotoxicosis and their effects on the pregnancy course.","authors":"Bagdagul Yuksel Guler, Ibrahim Demirci, Cem Haymana, Alper Sonmez, Ahmet Faruk Yagci","doi":"10.20945/2359-4292-2024-0129","DOIUrl":"10.20945/2359-4292-2024-0129","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical characteristics of patients with gestational transient thyrotoxicosis and its possible impacts on pregnancy.</p><p><strong>Methods: </strong>This retrospective study included pregnant women with gestational transient thyrotoxicosis who were admitted to our endocrinology outpatient clinic from June 2020 to March 2023. Patients with other causes of thyrotoxicosis, such as Graves' disease, toxic nodular goiter, and subacute thyroiditis, were excluded.</p><p><strong>Results: </strong>The study included 50 pregnant women who met the inclusion criteria and whose data could be accessed. Two pregnant women were diagnosed with gestational diabetes, and two pregnancies resulted in abortion. We observed that thyroid-stimulating hormone levels normalized to euthyroid values at a mean gestational age of 18.3 ± 3.7 weeks. The mean gestational age at birth was 38 ± 1.8 weeks. The frequency of preterm labor, defined as delivery before 37 weeks, was 10% (n = 5). Sinus rhythm was observed in 87% of the electrocardiograms obtained during thyrotoxicosis, while sinus tachycardia was detected in four and sinus arrhythmia in two cases. Thyroid nodules were observed in 23 (47.9%) of 48 cases in which ultrasonography was performed during thyrotoxicosis. Discussion: This retrospective study, including 50 pregnant women with gestational transient thyrotoxicosis, found no increase in the rate of serious obstetric complications such as eclampsia/preeclampsia, gestational diabetes, preterm labor, or abortion. Notably, in a detailed examination of electrocardiograms, which has not been done in previous studies, we did not detect any serious, life-threatening arrhythmias, although tachycardia was observed.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"69 2","pages":"e240129"},"PeriodicalIF":1.6,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11977610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信